Abstracts tagged "Assessment"

Abstract Number: 344 • 2017 ACR/ARHP Annual Meeting
Real World Clinical Trial Comparing the Patient Reported Outcomes Measurement Information System Short Forms and Profiles to CDAI Disease Classification in Rheumatoid Arthritis Patients
Jeffrey R. Curtis¹, Sergio Schwartzman², Shelly Kafka³, Dennis Parenti³, Shawn Black³, Stephen Xu⁴, Wayne Langholff⁴ and Clifton O. Bingham III⁵, ¹Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ²Weill Cornell Medical College, New York, NY, ³Janssen Scientific Affairs, LLC, Horsham, PA, ⁴Janssen Research & Development, LLC, Spring House, PA, ⁵Rheumatology, Johns Hopkins University, Baltimore, MD
Background/Purpose: Patient (Pt) reported outcomes (PROs) play a role in overall disease evaluation, therapeutic response assessment and care of rheumatoid arthritis (RA) patients (Pts). The…
Abstract Number: 424 • 2017 ACR/ARHP Annual Meeting
Re-Establishment of Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, in Rheumatoid Arthritis Patients after Temporary Discontinuation
Jeffrey Kaine¹, John Tesser², Ryan DeMasi³, Liza Takiya³, Lisy Wang⁴, Mark Snyder³, Haiyun Fan⁴ and Jürgen Wollenhaupt⁵, ¹Sarasota Arthritis Research Center, Sarasota, FL, ²Arizona Arthritis & Rheumatology Associates, Glendale, AZ, ³Pfizer Inc, Collegeville, PA, ⁴Pfizer Inc, Groton, CT, ⁵Schön-Klinik Hamburg-Eilbek Teaching Hospital of the University of Hamburg, Hamburg, Germany
Background/Purpose: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We assessed tofacitinib efficacy and safety after temporary discontinuation and…
Abstract Number: 1344 • 2017 ACR/ARHP Annual Meeting
Impact of Fibromyalgic RA on Composite Scores; Results from a Longitudinal Study of RA Patients Initiating Bdmard Therapy
Hilde B Hammer¹, Sella A. Provan², Brigitte Michelsen³, Till Uhlig⁴, Jon Lampa⁵ and Tore K Kvien⁶, ¹Rheumatology, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ³Rheumatology, Hospital of Southern Norway trust, Kristiansand, Norway, ⁴Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁵Karolinska Institute, Department of Medicine, Rheumatology Unit, Stockholm, Sweden, Stockholm, Sweden, ⁶On behalf of the NOR-DMARD registry, Oslo, Norway
Background/Purpose: The composite scores DAS28, CDAI and SDAI all include number of tender and swollen joints (of 28). Rheumatoid arthritis (RA) patients with tender to…
Abstract Number: 1621 • 2017 ACR/ARHP Annual Meeting
Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By the Automated Neuropsychological Assessment Metrics
Zahi Touma¹, Robin Green², Lesley Ruttan³, Sabrina Lombardi³, Carmela Tartaglia⁴, Nicole Anderson⁵, Jiandong Su⁶, Kenneth Colosimo⁶, Michelle Vitti⁶, Dennisse Bonilla⁶, Joan E. Wither⁵, Marvin J. Fritzler⁷ and Dorcas Beaton⁸, ¹Rheumatology, University of Toronto, Division of Rheumatology, Institute of Health Policy, Management and Evaluation, Toronto, ON, Canada, ²Brain and Therapeutics, Toronto Rehabilitation Institute, Toronto, ON, Canada, ³Toronto Rehabilitation Institute, Toronto, ON, Canada, ⁴University of Toronto, Krembil Neurosciences Centre, Toronto, ON, Canada, ⁵Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁶University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁷Medicine, University of Calgary, Calgary, AB, Canada, ⁸Mobility Program Clinical Research Unit, St Michael's Hospital, Toronto, ON, Canada
Background/Purpose: The screening and diagnosis of Cognitive Impairment (CI) in Systemic Lupus Erythematosus (SLE) patients is often delayed. CI diagnosed according to the American College…
Abstract Number: 1870 • 2017 ACR/ARHP Annual Meeting
Validation of an Electronic Version of the Michigan Body Map
Chad M. Brummett¹, David Kohns², Rishi Bakshi³, Jenna Goesling⁴, Stephanie Moser¹, Jennifer Pierce⁴, David Williams⁵, Daniel J. Clauw⁵, Afton L. Hassett¹ and Erin Spencer², ¹Anesthesiology, University of Michigan, Ann Arbor, MI, ²University of Michigan, Ann Arbor, MI, ³Physical Medicine Rehabilitaion, Univeristy of Michigan, Ann Arbor, MI, ⁴Department of Anesthesiology, University of Michigan, Ann Arbor, MI, ⁵Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI
Background/Purpose: We previously validated the Michigan Body Map (MBM) to accurately assess widespread body pain and as a means of administering the Widespread Pain Index…
Abstract Number: 2010 • 2017 ACR/ARHP Annual Meeting
Does PET CT Matter in Assessing Extent of Disease in Relapsing Polychondritis – a Single Center Pilot Study
Aman Sharma¹, Adarsh MB², Shankar Naidu³, Varun Dhir⁴, Roshan Verma⁵, Rajender Basher⁵, Anish Bhattacharya⁶, Sanjay Jain⁷ and B R Mittal⁶, ¹Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, ²Internal Medicine, PGIMER, Chandigarh, India, ³PGIMER, cHANDIGARH, India, ⁴Internal Medicine (Rheumatology Unit), Postgraduate Institute of Medical Education and Research, Chandigarh, India, ⁵PGIMER, Chandigarh, India, ⁶Nuclear Medicine, PGIMER, Chandigarh, India, ⁷PGIMER, CHANDIGARH, India
Background/Purpose: Relapsing polychondritis(RP) is a rare rheumatic disease involving cartilaginous and proteoglycan rich structures. Clinical examination and radiological investigations have limitations in assessing the extent…
Abstract Number: 2141 • 2017 ACR/ARHP Annual Meeting
Quantitative Nailfold Video Capillaroscopy Parameters Correlate with Dermatomyositis Activity and Damage
Hans Prakash¹, Diego Song¹, Daniel Lichy¹, Pranay Rao², Mina Jain³, Joseph Shrader³, Frederick W Miller⁴, Adam Schiffenbauer⁵, Alexander Gorbach¹ and Lisa G Rider⁵, ¹National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, ²National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, bethesda, MD, ³Rehabilitation Medicine Department, National Institutes of Health, Bethesda, MD, ⁴Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, ⁵Environmental Autoimmunity Grp, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD
Background/Purpose: To assess microvascular structure and function in patients with adult dermatomyositis (DM) and juvenile dermatomyositis (JDM), we have designed and built a mobile, high-resolution…
Abstract Number: 2862 • 2017 ACR/ARHP Annual Meeting
Diverse Disease Activity Measures Demonstrate That the Routine Assessment of Patient Index Data with 3 Measures (Rapid-3) Assesses Only Non Inflammatory Components of Disease and Should Not be Utilized in a Treat to Target Strategy in Rheumatoid Arthritis
Craig Wiesenhutter, Coeur d'Alene Arthritis Clinic, Coeur D Alene, ID
Background/Purpose: Treating Rheumatoid Arthritis (RA) patients to target (T2T) has been shown to result in better outcomes in patients with RA. Surrogate measures of disease…
Abstract Number: 2951 • 2017 ACR/ARHP Annual Meeting
Responsiveness of the Patient Reported Outcomes Measurement Information System to Golimumab Intravenous and Infliximab Treatment in a Real World Clinical Trial in Rheumatoid Arthritis Patients
Jeffrey R. Curtis¹, Douglas Conaway², Joy Schechtman³, Aaron Broadwell⁴, Alan J. Kivitz⁵, Vance Bray⁶, Shelly Kafka⁷, Dennis Parenti⁷, Shawn Black⁷, Stephen Xu⁸, Wayne Langholff⁸ and Clifton O. Bingham III⁹, ¹Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ²Rheumatology/Medicine, Carolina Health Specialists, Myrtle Beach, SC, ³Sun Valley Arthritis Center LTD, Peoria, AZ, ⁴Rheumatology Osteoporosis Specialists, Shreveport, LA, ⁵Altoona Arthritis & Osteoporosis Center, Altoona, PA, ⁶Denver Arthritis Clinic, Denver, CO, ⁷Janssen Scientific Affairs, LLC, Horsham, PA, ⁸Janssen Research & Development, LLC, Spring House, PA, ⁹Rheumatology, Johns Hopkins University, Baltimore, MD
Background/Purpose: The Patient (Pt) Reported Outcomes Measurement Information System (PROMIS [P]) questionnaires developed by the NIH have been validated and are a feasible assessment tool…
Abstract Number: 3062 • 2016 ACR/ARHP Annual Meeting
Use of Script Concordance Testing to Evaluate the Efficacy of a Web-Based Module on Gout: Three Years of Experience
Bernadette C. Siaton¹, Elizabeth Clayton², Alexandra M. Kueider³ and Matthew Rietschel⁴, ¹Rheumatology, University of Maryland School of Medicine, Baltimore, MD, ²Edmund J. MacLaughlin, M.D., L.L.C., Easton, MD, ³Laboratory of Behavioral Neuroscience -Unit of Clinical and Translational Neuroscience, National Institute on Aging, Baltimore, MD, ⁴University of Maryland School of Nursing, Baltimore, MD
Background/Purpose: Despite the prevalence of musculoskeletal conditions, the majority of internal medicine trainees at the University of Maryland complete residency with little exposure to rheumatology…
Abstract Number: 3154 • 2016 ACR/ARHP Annual Meeting
Assessing Bone Erosions in the Metatarsophalangeal Joints of Patients with Early Rheumatoid Arthritis: a Comparison Between MRI and Ultrasound
Karen A. Beattie¹, Sydney Scheffler², George Ioannidis³, Edward Schreyer⁴, Saara Totterman⁵ and Maggie Larche¹, ¹Medicine, McMaster University, Hamilton, ON, Canada, ²McMaster University, Hamilton, ON, Canada, ³St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, ⁴QMetrics Technologies, Rochester, NY, ⁵Radiology, VirtualScopics Inc., Rochester, NY
Background/Purpose: This cross-sectional study aimed to assess the agreement between Magnetic Resonance Imaging (MRI) and ultrasound (US) findings of bone erosions in the metatarsalphalangeal (MTP)…
Abstract Number: 1134 • 2016 ACR/ARHP Annual Meeting
Confidence and Competence of Medicine Trainees’ Musculoskeletal Skills: A Report of the Relationship from a Large Multi-Year, Multidisciplinary Cohort
Andrea M. Barker¹, Grant W. Cannon² and Michael J. Battistone¹, ¹Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ²Internal Medicine, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT
Background/Purpose: The Musculoskeletal (MSK) Education Week for medical students, residents, fellows, and trainees of other health professions has been sustained since 2011. The objective of…
Abstract Number: 2750 • 2016 ACR/ARHP Annual Meeting
Concordance Between Patient and Physician Global Assessment of the Disease in Patients with Psoriatic Arthritis
Josefina Gallino Yanzi¹, Osvaldo Luis Cerda², Margarita Landi², Cecilia Zaffarana², Emilce Schneeberger² and Gustavo Citera¹, ¹Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
Background/Purpose: In Rheumatoid Arthritis it has been observed a significant discrepancy in the global assessment of the disease by the patient and physician and this…
Abstract Number: 1296 • 2015 ACR/ARHP Annual Meeting
Evaluating Inter-Rater Reliability in Joint Count to Promote Quality and Trust in a Clinical Arthritis Care Team
Diane Tin¹, Lorna J. Bain¹, J Carter Thorne², Meen Jae Lee^2,3, Lois Derrick^1,4, E Jean Painter¹, Annabelle Estaban¹, Nooshin Samadi², Sue Charette¹, Sherry Hartnett¹, Carolyn Bornstein¹, Edward Ng² and Michael Aubrey², ¹The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ²Southlake Regional Health Centre, Newmarket, ON, Canada, ³Pharmacology, McGill University, Montreal, QC, Canada, ⁴The Arthritis Society, Toronto, ON, Canada
Background/Purpose: Joint count assessment is essential for the diagnosis and ongoing evaluation of Rheumatoid Arthritis (RA) disease activity. In our team based, interprofessional approach to…
Abstract Number: 1322 • 2015 ACR/ARHP Annual Meeting
How Can We Reduce the Time for Scoring Radiographic Joint Damage in Rheumatoid Arthritis? Initial Results with a New Computer-Based Documentation Tool
Alexander Langer¹, Joachim Böttcher², Diane M. Renz³, Alexander Pfeil⁴ and Hans-Eckhard Langer⁵, ¹Department of Computer Science, RWTH Aachen University, Aachen, Germany, ²Institute for Diagnostic and Interventional Radiology, SRH Waldklinikum, Gera, Germany, ³Institute for diagnostic and Interventional Radiology, Jena University Hospital - Friedrich Schiller University, Jena, Germany, ⁴Department of Internal Medicine III, Jena University Hospital - Friedrich Schiller University, Jena, Germany, ⁵RHIO (Rheumatology, Immunology, and Osteology), Duesseldorf, Germany
Background/Purpose: Radiographic progression is a key outcome parameter in RA1. Manual scoring of joint damage based on the established scoring methods (e. g. Sharp Score)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].